Follow the Alkem Laboratories Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Alkem Laboratories Limited has published 23 insider filings. Market capitalisation: €689.8bn. The latest transaction was disclosed on 29 March 2022 (Sale). Among the most active insiders: Deepak Kumar Singh. All data is free.
23
Insider Decl.
n/a
Thresholds
€306,892
12 ops.
Buy Volume
€3m
11 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alkem Laboratories Limited Buy (bullish), based on 20 analysts. Average price target: ₹5,964.80.
10Σ signal
Buys €306,892€3m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,879 of 28,752 companies
61.1
score / 100
Value
42
Quality
80
FCF yld2.0%
Earn yld3.3%
EV/EBITDA21.1x
ROE18%
Gross mgn64%
Net mgn16%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 shares@ ₹3,098.96140.0001% mcap100.0% of flowEquity SharesSEBI:0c16f021b9ef6137d948747a1c4ab5c794340bcb
23 of 23 declarations
About Alkem Laboratories Limited
Alkem Laboratories Limited is an Indian pharmaceutical company that specializes in the manufacturing of generic drugs and health products. It is listed on the Bombay Stock Exchange.